Holen Sie sich die Stockscreener-App
71.51
1.05%
-0.76
Handel nachbörslich:
71.51
Schlusskurs vom Vortag:
$72.27
Offen:
$72.58
24-Stunden-Volumen:
343.43K
Relative Volume:
0.59
Marktkapitalisierung:
$3.51B
Einnahmen:
$404.36M
Nettoeinkommen (Verlust:
$146.64M
KGV:
23.08
EPS:
3.0983
Netto-Cashflow:
$226.10M
1W Leistung:
-2.56%
1M Leistung:
-6.74%
6M Leistung:
-18.35%
1J Leistung:
-7.50%
1-Tages-Spanne:
$70.80
$72.58
1-Wochen-Bereich:
$70.80
$73.01
52-Wochen-Spanne:
$67.94
$91.38
National Health Investors Inc Stock (NHI) Company Profile
Firmenname
National Health Investors Inc
Sektor
Telefon
(615) 890-9100
Adresse
222 ROBERT ROSE DRIVE, MURFREESBORO, TN
Compare NHI vs WELL, VTR, DOC, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NHI
National Health Investors Inc
|
71.51 | 3.63B | 404.36M | 146.64M | 226.10M | 3.0983 |
WELL
Welltower Inc
|
238.59 | 171.06B | 11.75B | 1.46B | 2.19B | -0.6014 |
VTR
Ventas Inc
|
92.06 | 47.54B | 6.13B | 272.21M | 1.38B | 0.5521 |
DOC
Healthpeak Properties Inc
|
21.03 | 14.62B | 2.87B | 250.10M | 1.13B | 0.3188 |
OHI
Omega Healthcare Investors Inc
|
46.99 | 14.17B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
56.21 | 12.16B | 2.37B | 101.67M | 169.19M | 0.5775 |
National Health Investors Inc Stock (NHI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-07-10 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-02 | Hochstufung | Truist | Hold → Buy |
| 2024-10-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-09-24 | Eingeleitet | BofA Securities | Buy |
| 2024-03-12 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2024-02-26 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-02-26 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-28 | Eingeleitet | Berenberg | Hold |
| 2023-09-20 | Eingeleitet | Jefferies | Hold |
| 2023-04-20 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-12-09 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2022-06-21 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Underperform |
| 2022-01-07 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2021-11-09 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2021-06-18 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-03-30 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2021-01-13 | Herabstufung | Mizuho | Neutral → Underperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2020-12-14 | Hochstufung | KeyBanc Capital Markets | Underweight → Sector Weight |
| 2020-12-02 | Herabstufung | Berenberg | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-06-08 | Fortgesetzt | JMP Securities | Mkt Perform |
| 2020-05-22 | Herabstufung | Mizuho | Buy → Neutral |
| 2020-02-05 | Eingeleitet | Berenberg | Buy |
| 2020-01-07 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2019-12-20 | Fortgesetzt | Mizuho | Buy |
| 2018-05-11 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2017-12-20 | Herabstufung | KeyBanc Capital Mkts | Sector Weight → Underweight |
| 2017-10-23 | Eingeleitet | CapitalOne | Equal Weight |
| 2017-10-11 | Eingeleitet | SunTrust | Hold |
| 2017-05-22 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2016-08-08 | Bestätigt | Mizuho | Neutral |
| 2016-03-11 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2015-11-09 | Bestätigt | Stifel | Buy |
| 2015-05-08 | Bestätigt | Mizuho | Neutral |
| 2015-03-03 | Bestätigt | Mizuho | Neutral |
| 2014-09-04 | Eingeleitet | Mizuho | Neutral |
| 2012-02-16 | Herabstufung | Hilliard Lyons | Neutral → Underperform |
Alle ansehen
National Health Investors Inc Aktie (NHI) Neueste Nachrichten
NewEdge Wealth LLC Purchases New Stake in National Health Investors, Inc. $NHI - MarketBeat
NHC CEO Stephen Flatt sells $355,620 in company shares By Investing.com - Investing.com Nigeria
Is National Health Investors (NHI) Undervalued After Its Earnings And Dividend Update? - Sahm
National HealthCare Corp stock hits all-time high at 232.78 USD - Investing.com South Africa
National Health Investors (NYSE: NHI) lines up Schwab stock sale for 2026 - Stock Titan
National Health Investors (NHI) Could Be 11% Undervalued On Its New COO Appointment - Sahm
How Stronger Q2 Results And A Higher Dividend At National Health Investors (NHI) Has Changed Its Investment Story - simplywall.st
PEB or NHI: Which Is the Better Value Stock Right Now? - Yahoo Finance
Cantor Fitzgerald Maintains National Health Investors Inc(NHI.US) With Buy Rating, Cuts Target Price to $90 - Moomoo
National Health Investors, Inc. (NYSE:NHI) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
National Health Investors, Inc. (NHI) Stock Forecasts - Yahoo Finance
Christian Ken Maingot Net Worth (2026) - GuruFocus
Analysts Offer Insights on Real Estate Companies: Ryman (RHP) and National Health Investors (NHI) - The Globe and Mail
National Health Investors: Buy The Earnings Dip And Lock In A 5.3% Yield (NYSE:NHI) - Seeking Alpha
Analysts Conflicted on These Real Estate Names: Simon Property (SPG) and National Health Investors (NHI) - The Globe and Mail
Earnings call transcript: NHI tops Q2 2026 EPS forecasts, revenue misses - Investing.com UK
National Health Investors (NHI) Stock Price Sinks As SHOP Pivot Raises Doubts - Sahm
(NHI) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
A Look at National Health Investors Inc (NHI) After 5.7% Decline -- GF Value $81.48 vs Price $69.95 - GuruFocus
Is National Health Investors (NHI) Undervalued After Its New COO Appointment? - Sahm
National Health Investors Inc (NHI) (Q2 2026) Earnings Call Highlights: Strategic Pivot to SHOP ... - Yahoo Finance UK
National Health Investors, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:NHI) 2026-08-11 - Seeking Alpha
National Health Investors Drops 5.3% Amid Sector-Wide Selling - AlphaStreet
National Health Investors Q2 Earnings Call Highlights - MarketBeat
National Health Investors (NYSE:NHI) Trading Down 5.2%Here's What Happened - MarketBeat
NHI: NHC sale and SHOP expansion drove strong earnings growth and robust liquidity - TradingView
NHI Q2 2026 slides: major portfolio shift toward private-pay housing - Investing.com
National Health Investors, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
National Health Investors earnings beat by $0.28, revenue fell short of estimates By Investing.com - Investing.com Nigeria
National Health Investors, Inc. (NHI) stock price, news, quote and history - Yahoo Finance Australia
Wells Fargo Maintains National Health Investors Inc(NHI.US) With Hold Rating, Cuts Target Price to $79 - 富途牛牛
NHI SWOT Analysis: Strong Revenue Growth and Strategic Asset Man - GuruFocus
Pensionfund Sabic's National Health Investors Inc(NHI) Holding History - GuruFocus
National Health Investors issues investor update for stakeholders - scanx.trade
All eyes on National Health Investors earnings as revenue declines By Investing.com - Investing.com UK
National Health Investors Q2 Results: Diluted EPS rises 45.6% YoY - scanx.trade
National Health Investors (NHI) Q2 FFO Lag Estimates - Yahoo Finance
National Health Investors, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
National Health Investors affirms FY26 FFO guidance of $4.74-$4.79 - scanx.trade
National Health Investors (NYSE:NHI) Releases FY 2026 Earnings Guidance - MarketBeat
National Health Investors (NYSE:NHI) Announces Earnings Results, Beats Estimates By $0.31 EPS - MarketBeat
National Health Investors Q2 revenue beats estimates on acquisitions, SHOP growth - TradingView
National Health Investors Q2 Normalized FFO Declines, Revenue Rises - marketscreener.com
National Health Investors: Q2 Earnings Snapshot - marketscreener.com
National Health Investors (NYSE: NHI) boosts profit, sells $560M NHC portfolio - Stock Titan
Earnings Flash (NHI) National Health Investors, Inc. Reports Q2 Revenue $121.3M, vs. FactSet Est of $72.1M - marketscreener.com
EDGAR Filing Documents for 0000877860-26-000201 - SEC.gov
NHI: Q2 2026 revenue rose 33.8% and net income jumped 50.5% year-over-year, with strong SHOP growth - TradingView
National Health Investors (NYSE: NHI) releases Q2 2026 investor update materials - Stock Titan
National Health Investors (NHI) outlines Q2 2026 NOI, lease mix and debt profile - Stock Titan
National Health Investors (NHI) boosts earnings and reshapes portfolio with $560M NHC sale - Stock Titan
Finanzdaten der National Health Investors Inc-Aktie (NHI)
Umsatz
Nettogewinn
Free Cashflow
ENV
National Health Investors Inc-Aktie (NHI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MCCABE ROBERT A JR | Director |
Jun 15 '26 |
Buy |
71.65 |
890 |
63,767 |
44,159 |
| Mendelsohn D. Eric | CEO and President |
Jun 05 '26 |
Buy |
68.84 |
1,500 |
103,260 |
133,316 |
| Spaid John L | CFO/EVP Finance |
Mar 03 '26 |
Option Exercise |
73.34 |
15,000 |
1,100,100 |
69,849 |
| Travis David L | SVP/Chief Accounting Officer |
Feb 23 '26 |
Option Exercise |
57.76 |
25,000 |
1,444,000 |
57,122 |
| PASCOE KEVIN CARLTON | Chief Investment Officer |
Feb 23 '26 |
Option Exercise |
57.76 |
8,500 |
490,960 |
74,765 |
| Mendelsohn D. Eric | CEO and President |
Feb 23 '26 |
Option Exercise |
57.76 |
13,334 |
770,172 |
128,784 |
| Spaid John L | CFO/EVP Finance |
Feb 23 '26 |
Option Exercise |
57.76 |
8,500 |
490,960 |
57,182 |
| COLDEN TRACY M J | Director |
Feb 19 '26 |
Option Exercise |
73.34 |
10,000 |
733,400 |
19,857 |
| Mendelsohn D. Eric | CEO and President |
Feb 17 '26 |
Option Exercise |
73.34 |
25,000 |
1,833,500 |
137,505 |
| Jobe James R | Director |
Feb 17 '26 |
Option Exercise |
73.34 |
10,000 |
733,400 |
41,555 |
0.74%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):